A detailed history of Consolidated Investment Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Consolidated Investment Group LLC holds 26,900 shares of ABBV stock, worth $5.27 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
26,900
Previous 26,900 -0.0%
Holding current value
$5.27 Million
Previous $4.9 Million 5.82%
% of portfolio
0.72%
Previous 0.79%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$159.82 - $182.1 $1.97 Million - $2.24 Million
12,300 Added 84.25%
26,900 $4.9 Million
Q3 2023

Oct 19, 2023

BUY
$133.59 - $154.65 $480,924 - $556,740
3,600 Added 32.73%
14,600 $2.18 Million
Q1 2023

Apr 27, 2023

BUY
$144.61 - $166.54 $1.59 Million - $1.83 Million
11,000 New
11,000 $1.75 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $346B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Consolidated Investment Group LLC Portfolio

Follow Consolidated Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consolidated Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Consolidated Investment Group LLC with notifications on news.